Leerink says cancer vaccine win should sustain Merck momentum into fall
Leerink says a cancer vaccine win should sustain Merck momentum into fall, with the note referencing MRNA, BNTX and MRK and supplying no further catalyst details.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.